Trump to name former pharmaceutical exec to lead U.S. coronavirus vaccine push

Must Read

Fort St. John RCMP looking for missing 60-year-old

FORT ST. JOHN, B.C. - The Fort St. John RCMP are looking for the public's help to...

No injuries as fire aboard Suncor’s Terra Nova vessel extinguished

ST. JOHN'S, N.L. — Suncor Energy officials say a fire onboard the Terra Nova Floating Production Storage and Offloading vessel...

One more new case of COVID-19 in the Northern Health region

VICTORIA, B.C. – There is one new case of COVID-19 in the Northern Health region, bringing our...

By ZEKE MILLER The Associated Press

Posted May 13, 2020 9:48 pm

Updated May 13, 2020 9:50 pm

- Advertisement -

Community Interviews with Moose FM

1:20Coronavirus outbreak: White House says Trump will push drug companies to make affordable vaccines

When discussing possible future vaccines for COVID-19 on Tuesday, White House press secretary Kayleigh McEnany would not commit to whether President Donald Trump would ensure people will get the vaccine regardless of income, but said he would push pharmaceutical companies to make vaccines affordable.

President Donald Trump is set to name a former pharmaceutical executive to lead his administration’s all-out effort to produce and distribute a coronavirus vaccine by the end of the year.

Moncef Slaoui, a former GlaxoSmithKline executive, will lead “Operation Warp Speed,” Trump’s push to accelerate the vaccine development process for COVID-19, according to an administration official. Slaoui is to serve in a volunteer capacity, and will be assisted by Army Gen. Gustave Perna, the commander of United States Army Materiel Command.

The move comes as the president and White House aides hope to produce vaccines for the coronavirus faster than what many scientists believe is realistic.


More Articles Like This